Drug Shortage Report for WELLBUTRIN XL

Last updated on 2019-04-03 History
Report ID 71883
Drug Identification Number 02275104
Brand name WELLBUTRIN XL
Common or Proper name WELLBUTRIN XL
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 90's
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-02-03
Estimated end date
Actual end date 2019-04-02
Shortage status Resolved
Updated date 2019-04-03
Company comments Allocating inventory to support regular demand.
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2019-04-03 French Compare
v22 2019-04-03 English Compare
v21 2019-03-22 French Compare
v20 2019-03-22 English Compare
v19 2019-03-15 French Compare
v18 2019-03-15 English Compare
v17 2019-03-15 English Compare
v16 2019-03-05 French Compare
v15 2019-03-05 English Compare
v14 2019-02-27 French Compare
v13 2019-02-27 English Compare
v12 2019-02-04 French Compare
v11 2019-02-04 English Compare
v10 2019-01-28 French Compare
v9 2019-01-28 English Compare
v8 2019-01-28 English Compare
v7 2019-01-15 French Compare
v6 2019-01-15 English Compare
v5 2019-01-14 French Compare
v4 2019-01-14 English Compare

Showing 1 to 20 of 23